LEADER 02944nam  22004935  450 
001 9910350219803321
005 20200706123619.0
010   $a981-13-5793-5
024 7 $a10.1007/978-981-13-5793-0
035   $a(CKB)5340000000061434
035   $a(MiAaPQ)EBC5928038
035   $a(DE-He213)978-981-13-5793-0
035   $a(PPN)26217507X
035   $a(EXLCZ)995340000000061434
100   $a20190903d2019      u|             0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aHealth Technology Assessment in Japan$b[electronic resource] $ePolicy, Pharmacoeconomic Methods and Guidelines, Value, and Beyond /$fby Isao Kamae
205   $a1st ed. 2019.
210  1$aSingapore :$cSpringer Singapore :$cImprint: Adis,$d2019.
215   $a1 online resource (xvi, 269 pages) $cillustrations
311   $a981-13-5792-7 
327   $a1. Basics to Know -- 2. New HTA Policy in Japan -- 3. MHLW Guideline for Cost-effectiveness Analysis -- 4. How to Appraise -- 5. Exercises for Powerful Assessment -- 6. Intermediate Level Methods -- 7?Advanced Research Topics.
330   $aRepresenting the first book on the topic, this work offers the reader an introduction to the Japanese systems for health technology assessment (HTA) officially introduced by the Ministry of Health, Labour and Welfare (MHLW) in 2016. Policy and guidelines are discussed, with the relevant methods and conditions of cost-effectiveness analysis explained alongside. Numerous instructive examples and exercises, ranging from basic to advanced, impart valuable knowledge and insight on the quantitative methods for economic evaluation, which will appeal to both beginners and experts. This guidebook is authored by Japan?s foremost expert in HTA and pharmacoeconomics, with a view to strengthening the reader?s expertise in value-based healthcare and decision-making. The methods presented are essential to informing regulatory, local and patient decisions; as such, the book is equally recommended to industry and government, as well as academia, and anyone with an interest in Japanese HTA.
606   $aHealth economics
606   $aPharmacy management
606   $aHealth Economics$3https://scigraph.springernature.com/ontologies/product-market-codes/W35000
606   $aPharmacoeconomics and Health Outcomes$3https://scigraph.springernature.com/ontologies/product-market-codes/H69020
615  0$aHealth economics.
615  0$aPharmacy management.
615 14$aHealth Economics.
615 24$aPharmacoeconomics and Health Outcomes.
676   $a338.433621
700   $aKamae$b Isao$4aut$4http://id.loc.gov/vocabulary/relators/aut$0782252
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910350219803321
996   $aHealth Technology Assessment in Japan$91735044
997   $aUNINA